A Study of Radiotherapy Planning System Software ---- Zeus Cloud

NCT ID: NCT04579718

Last Updated: 2020-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

63 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-01

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the feasibility of Zeus Cloud TPS in the design of photon intensity modulated radiation therapy (IMRT) plan for tumors in various parts of the body.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a self-control, multi-center non-inferiority study. Subjects meeting inclusion criteria have radiation treatment plans designed by Zeus Cloud TPS and Eclipse treatment planning software from Varian, respectively. The qualities of two plans are compared.

This is a observational study as the two plans are not executed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eclipse

Eclipse

Intervention Type OTHER

Eclipse TPS of Varian company is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Zeus Cloud TPS V1.0

Zeus Cloud TPS V1.0

Intervention Type OTHER

Zeus Cloud TPS V1.0 is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zeus Cloud TPS V1.0

Zeus Cloud TPS V1.0 is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Intervention Type OTHER

Eclipse

Eclipse TPS of Varian company is used to design the radiotherapy plan for the subjects and the plan is evaluated.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with confirmed brain glioma, nasopharyngeal carcinoma, lung cancer, esophageal cancer, gastric cancer, liver cancer, prostate cancer, cervical cancer and rectal cancer;
2. The medical imaging data (CT) of the subjects were complete and available;
3. Between 18 and 75 years old, regardless of gender;

Exclusion Criteria

1. The patients had metal implants;
2. Not suitable for clinical trials judged by investigators.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

The Affilicated Suzhou Science and Technology Town Hospital

UNKNOWN

Sponsor Role collaborator

Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hui Liu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hui Liu, Prof.

Role: PRINCIPAL_INVESTIGATOR

Sun Yat-sen University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bo Qiu, MD

Role: CONTACT

+86-020-87343031

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GASTO-1062

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.